Latest filings (excl ownership)
S-1
IPO registration
8 May 24
8-K
Departure of Directors or Certain Officers
26 Apr 24
8-K
Range Impact Reports 4Q 2023 and Full Year 2023 Financial Results
29 Mar 24
10-K
2023 FY
Annual report
29 Mar 24
8-K
Range Impact Announces $1.7 Million Capital Raise Led by Strategic Investors
21 Dec 23
8-K
Entry into a Material Definitive Agreement
14 Dec 23
8-K
Malachite Innovations Reports Third Quarter 2023 Results
14 Nov 23
8-K/A
Other Events
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Entry into a Material Definitive Agreement
1 Nov 23
8-K
Malachite Innovations Announces Closing the Acquisition of Its Third Reclamation Business In West Virginia
5 Sep 23
8-K
Entry into a Material Definitive Agreement
30 Aug 23
8-K
Malachite Innovations Reports Second Quarter 2023 Results
1 Aug 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
8-K
Malachite Innovations Reports First Quarter 2023 Results
31 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Malachite Innovations Announces Capital Raise Led by Bernie Kosar, Edward Feighan and Two Outside Private Investment Firms
13 Apr 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
12 Oct 22
8-K/A
Other Events
22 Sep 22
8-K
Entry into a Material Definitive Agreement
29 Aug 22
8-K
Other Events
16 Aug 22
NT 10-Q
Notice of late quarterly filing
16 Aug 22
8-K
Entry into a Material Definitive Agreement
15 Jul 22
8-K
Malachite Innovations Announces Closing of $3.0 Million Capital Raise and Initial Esg Acquisitions
13 May 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-KT
Annual report (with FYE transition)
31 Mar 22
8-K
Malachite Innovations Announces Signed Letter of
15 Mar 22
8-K
Amendments to Articles of Incorporation or Bylaws
9 Mar 22
8-K
Malachite Innovations Announces Two Granted
28 Dec 21
10-Q
2021 Q2
Quarterly report
15 Nov 21
8-K
Entry into a Material Definitive Agreement
12 Oct 21
S-8
Registration of securities for employees
3 Sep 21
8-K
Vitality Biopharma Announces Effective S-1 Registration Statement and DTC Eligibility
2 Sep 21
424B1
Prospectus with pricing info
2 Sep 21
EFFECT
Notice of effectiveness
2 Sep 21
CORRESP
Correspondence with SEC
1 Sep 21
S-1/A
IPO registration (amended)
31 Aug 21
UPLOAD
Letter from SEC
31 Aug 21
Latest ownership filings
4
EDWARD F FEIGHAN
12 Jan 24
4
Michael R. Cavanaugh
12 Jan 24
4
Richard F Celeste
12 Jan 24
4
Michael R. Cavanaugh
26 Dec 23
4
EDWARD F FEIGHAN
26 Dec 23
4
Joseph E. LoConti
14 Dec 23
4/A
Change in insider ownership (amended)
7 Nov 23
SC 13G/A
Indemnity National Insurance Co
7 Nov 23
4
Joseph E. LoConti
3 Nov 23
SC 13G/A
Indemnity National Insurance Co
29 Aug 23
4
Change in insider ownership
29 Aug 23
4
EDWARD F FEIGHAN
4 May 23
4
EDWARD F FEIGHAN
13 Apr 23
5
Richard F Celeste
31 Mar 23
5
Brandon Joel Zipp
31 Mar 23
5
Michael R. Cavanaugh
31 Mar 23
5
RICHARD MCKILLIGAN
31 Mar 23
5
EDWARD F FEIGHAN
31 Mar 23
SC 13G
Indemnity National Insurance Co
1 Jun 22
SC 13D/A
LoConti Joseph E.
27 May 22
3
Initial statement of insider ownership
18 May 22
4
Joseph E. LoConti
12 May 22
4
EDWARD F FEIGHAN
13 Dec 21
4
Brandon Joel Zipp
13 Dec 21
4
Michael R. Cavanaugh
13 Dec 21
4
Richard F Celeste
13 Dec 21
4
RICHARD MCKILLIGAN
13 Dec 21
4
Joseph E. LoConti
26 Aug 21
4
Brandon Joel Zipp
9 Feb 21
3
Brandon Joel Zipp
23 Oct 20
4
RICHARD MCKILLIGAN
1 Jul 19
4
Michael R. Cavanaugh
1 Jul 19
4
EDWARD F FEIGHAN
1 Jul 19
3
RICHARD MCKILLIGAN
20 May 19
3
Richard F Celeste
20 May 19
4
Richard F Celeste
20 May 19
4
ANTHONY E MAIDA III
13 May 19
4
Michael R. Cavanaugh
13 May 19
4
EDWARD F FEIGHAN
13 May 19
4/A
Robert T. Brooke
25 Apr 19